Transcriptomic characterization of fibrolamellar hepatocellular carcinoma

EP Simon, CA Freije, BA Farber… - Proceedings of the …, 2015 - National Acad Sciences
EP Simon, CA Freije, BA Farber, G Lalazar, DG Darcy, JN Honeyman, R Chiaroni-Clarke…
Proceedings of the National Academy of Sciences, 2015National Acad Sciences
Fibrolamellar hepatocellular carcinoma (FLHCC) tumors all carry a deletion of∼ 400 kb in
chromosome 19, resulting in a fusion of the genes for the heat shock protein, DNAJ (Hsp40)
homolog, subfamily B, member 1, DNAJB1, and the catalytic subunit of protein kinase A,
PRKACA. The resulting chimeric transcript produces a fusion protein that retains kinase
activity. No other recurrent genomic alterations have been identified. Here we characterize
the molecular pathogenesis of FLHCC with transcriptome sequencing (RNA sequencing) …
Fibrolamellar hepatocellular carcinoma (FLHCC) tumors all carry a deletion of ∼400 kb in chromosome 19, resulting in a fusion of the genes for the heat shock protein, DNAJ (Hsp40) homolog, subfamily B, member 1, DNAJB1, and the catalytic subunit of protein kinase A, PRKACA. The resulting chimeric transcript produces a fusion protein that retains kinase activity. No other recurrent genomic alterations have been identified. Here we characterize the molecular pathogenesis of FLHCC with transcriptome sequencing (RNA sequencing). Differential expression (tumor vs. adjacent normal tissue) was detected for more than 3,500 genes (log2 fold change ≥1, false discovery rate ≤0.01), many of which were distinct from those found in hepatocellular carcinoma. Expression of several known oncogenes, such as ErbB2 and Aurora Kinase A, was increased in tumor samples. These and other dysregulated genes may serve as potential targets for therapeutic intervention.
National Acad Sciences